Portland, OR, May 31, 2022 (GLOBE NEWSWIRE) — Allied Market Research published a report, titled, “Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market by Product (Normal balloon catheter, Drug eluting balloon catheter, Cutting balloon catheter, Scoring balloon catheter), by Delivery Platform (Rapid Exchange (RX) / Monorail balloon catheter, Over-the-wire (OTW) balloon catheter), by Compliance (Semi-Compliant, Non-Compliant), by Balloon Material (Polyolefin copolymer (POC), Polyethylene (PE), Polyethylene terephthalate (PET)): Global Opportunity Analysis and Industry Forecast, 2021-2031”. According to the report, the global percutaneous transluminal coronary angioplasty (PTCA) balloon catheters industry generated $1.2 billion in 2020, and is anticipated to generate $1.8 billion by 2031, witnessing a CAGR of 4.4% from 2022 to 2031.
Download Sample Report- https://www.alliedmarketresearch.com/request-sample/2635
Prime determinants of growth
Rise in geriatric population, surge in number of minimally invasive surgeries, increase in hospitalization with surge in cardiovascular disorders, rise in demand for angioplasty over conventional surgeries, and increase in the number of catheterization laboratories drive the growth of the global percutaneous transluminal coronary angioplasty (PTCA) balloon catheters market. Moreover, rise in technological breakthroughs & modernization in healthcare equipment and surge in healthcare research and…
